Status:
COMPLETED
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
Lead Sponsor:
Kowa Research Europe
Conditions:
Type II Diabetes Mellitus
Dyslipidemia
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind extension study for patients who participated in study NK-104-305.
Eligibility Criteria
Inclusion
- Type II diabetes mellitus
- Combined dyslipidemia
- Completed NK-104-305 (NCT00309751)
Exclusion
- Withdrawal from NK-104-305 (NCT00309751)
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT00344370
Start Date
August 1 2006
End Date
April 1 2008
Last Update
February 2 2010
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
CCBR Aalborg
Aalborg, Denmark
2
CCBR A/S
Vejle, Denmark
3
CCBR Vejle
Vejle, Denmark
4
Gemeinschaftspraxis am Bahnhof
Berlin-Spandau, Germany